Ep 43: Mucosal Melanoma
Melanoma Matters14 Okt 2024

Ep 43: Mucosal Melanoma

Summary

In this episode of Melanoma Matters, Sapna and James discuss the importance of looking at Figure 1. They talk about in-flight medical emergencies, and James recalls a scene of carnage ... "blood everywhere."


They delve into the complexities of mucosal melanoma, discussing its unique characteristics, treatment options, and the latest research findings. They share personal anecdotes from their medical experiences, emphasizing the importance of understanding the nuances of this melanoma subtype. The conversation covers the efficacy of checkpoint inhibitors, the significance of various studies, and considerations for adjuvant and neoadjuvant therapies. The hosts also highlight the need for tailored approaches in treating mucosal melanoma patients, given the disease's heterogeneity and geographical variations.


Keywords

Mucosal Melanoma, Checkpoint Inhibitors, Adjuvant Therapy, Neoadjuvant Therapy, Oncology, Cancer Treatment, Medical Stories, Clinical Trials, Patient Care, Melanoma Research


Takeaways

Mucosal melanoma is a unique subtype that requires specific attention.

Checkpoint inhibitors have shown efficacy in treating mucosal melanoma.

Understanding geographical variations is crucial in melanoma treatment.

Clinical trials often exclude mucosal melanoma patients, impacting data.

Adjuvant therapy may be beneficial but is not universally applicable.

Neoadjuvant therapy could be a reasonable option for certain patients.

Response rates vary significantly based on the anatomical site of the melanoma.

Patient performance status plays a critical role in treatment decisions.

The importance of thorough data collection in clinical trials cannot be overstated.

Personal anecdotes from physicians highlight the unpredictable nature of medical emergencies.


Titles

Emergency Medical Stories: A Doctor's Perspective

Comparative Studies in Mucosal Melanoma Treatment


Sound Bites

"I think we actually missed this figure."

"Always look at Figure 1."


Chapters

00:00 Introduction to Mucosal Melanoma

05:21 Anecdotes from the Medical Field

08:19 Understanding Mucosal Melanoma

14:25 Sapna and James look at Figure 1

20:21 Comparative Analysis of Studies

26:30 Adjuvant and Neoadjuvant Therapies for Mucosal Melanoma


Episoder(84)

Ep 81: IGNYTE trial (RP1 + nivo)

Ep 81: IGNYTE trial (RP1 + nivo)

SummaryThe conversation covers the published data from the IGNYTE study - RP1 + nivolumab: response rate and safety profile, RNA-seq analysis, and toxicity. The key takeaways include insights into cli...

13 Feb 32min

Ep 80: 2025 Holiday Special

Ep 80: 2025 Holiday Special

SummaryHappy Holidays and Festive Season Everyone! In this episode of Melanoma Matters, hosts Sapna Patel and James reflect on their "cultural" experiences over the past year, discussing movies, music...

30 Des 202535min

Ep 79: coBRIM, COMBI-d 5-year follow-up

Ep 79: coBRIM, COMBI-d 5-year follow-up

SummaryIn this episode of Melanoma Matters, James awaits an invitation to a film premiere (The Penguin Lessons) and we all await a picture of him in his tuxedo! Sapna and James go on to discuss the 5-...

29 Des 202536min

Ep 78 TRAILER: MEK inhibitor trials

Ep 78 TRAILER: MEK inhibitor trials

Enjoy this short trailer on MEK inhibitor monotherapy trials in melanoma

29 Des 20251min

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

Ep 78: MEK inhibitor trials (METRIC, NEMO, pimasertib)

SummarySo many shoutouts in this episode of Melanoma Matters! Sapna and James engage in a lively discussion about MEK inhibitors as monotherapy treatment. They explore the METRIC, NEMO, and pimasertib...

29 Des 202537min

Ep 77: Guest Merrick Ross

Ep 77: Guest Merrick Ross

SummaryIn this episode of Melanoma Matters, hosts James Larkin and Sapna Patel engage with Merrick Ross, a seasoned surgical oncologist, discussing his background, the evolution of surgical practice w...

29 Des 202544min

Ep 76: KEYNOTE 054 7-year follow-up

Ep 76: KEYNOTE 054 7-year follow-up

SummaryIn this Episode, hosts James & Sapna go into the 7-year follow-up from the randomized phase 3 adjuvant trial of pembrolizumab versus placebo for stage III melanoma, KEYNOTE-054There's a bit too...

28 Des 202528min

Ep 75: Immune-mediated Myocarditis

Ep 75: Immune-mediated Myocarditis

SummaryIn this (longest to-date) episode, James and Sapna delve into the not-so-rare occurence of immune-mediated myocarditis, particularly in the context of immune checkpoint inhibitors. The hosts di...

28 Des 20251h 4min

Populært innen Helse

fastlegen
rss-gukild-johaug
lydartikler-fra-aftenposten
hvordan-har-du-det-mann
psykodrama
leger-om-livet
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-garne-damer
foreldreradet
bak-fasaden-en-reise-i-livet-med-sykepleier-ine
morten-ramm-lar-kakla-ga-til-du-sovner
rss-lopedrommen
hormonelle-frida
klimaks
hjernesterk
rss-femihelse
g-punktet
rss-sunn-okonomi
treningsprat
rss-skravla-gar